SK285662B6 - Farmaceutický prostriedok obsahujúci molekulovú disperziu tricyklickej amidovej zlúčeniny - Google Patents

Farmaceutický prostriedok obsahujúci molekulovú disperziu tricyklickej amidovej zlúčeniny Download PDF

Info

Publication number
SK285662B6
SK285662B6 SK896-2000A SK8962000A SK285662B6 SK 285662 B6 SK285662 B6 SK 285662B6 SK 8962000 A SK8962000 A SK 8962000A SK 285662 B6 SK285662 B6 SK 285662B6
Authority
SK
Slovakia
Prior art keywords
compound
molecular dispersion
mixture
pluronic
formula
Prior art date
Application number
SK896-2000A
Other languages
English (en)
Slovak (sk)
Other versions
SK8962000A3 (en
Inventor
Surendra A. Sangekar
Ping I. Lee
Amin A. Nomeir
Original Assignee
Schering Corporation
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Schering Corporation filed Critical Schering Corporation
Publication of SK8962000A3 publication Critical patent/SK8962000A3/sk
Publication of SK285662B6 publication Critical patent/SK285662B6/sk

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445—Non condensed piperidines, e.g. piperocaine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445—Non condensed piperidines, e.g. piperocaine
    • A61K31/4523—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems
    • A61K31/4545—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems containing a six-membered ring with nitrogen as a ring hetero atom, e.g. pipamperone, anabasine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/4427—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems
    • A61K31/444—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems containing a six-membered ring with nitrogen as a ring heteroatom, e.g. amrinone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/141—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers
    • A61K9/146—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers with organic macromolecular compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/2027—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4841—Filling excipients; Inactive ingredients
    • A61K9/4866—Organic macromolecular compounds

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Plural Heterocyclic Compounds (AREA)
SK896-2000A 1997-12-22 1998-12-17 Farmaceutický prostriedok obsahujúci molekulovú disperziu tricyklickej amidovej zlúčeniny SK285662B6 (sk)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US99716897A 1997-12-22 1997-12-22
PCT/US1998/026218 WO1999032118A1 (en) 1997-12-22 1998-12-17 Molecular dispersion composition with enhanced bioavailability

Publications (2)

Publication Number Publication Date
SK8962000A3 SK8962000A3 (en) 2001-07-10
SK285662B6 true SK285662B6 (sk) 2007-05-03

Family

ID=25543717

Family Applications (1)

Application Number Title Priority Date Filing Date
SK896-2000A SK285662B6 (sk) 1997-12-22 1998-12-17 Farmaceutický prostriedok obsahujúci molekulovú disperziu tricyklickej amidovej zlúčeniny

Country Status (28)

Country Link
EP (1) EP1039908B1 (zh)
JP (2) JP2001526227A (zh)
KR (1) KR100597331B1 (zh)
CN (1) CN1116039C (zh)
AR (1) AR017436A1 (zh)
AT (1) ATE260105T1 (zh)
AU (1) AU761994C (zh)
BR (1) BR9813728A (zh)
CA (1) CA2315685C (zh)
CO (1) CO4970793A1 (zh)
CZ (1) CZ295956B6 (zh)
DE (1) DE69821984T2 (zh)
DK (1) DK1039908T3 (zh)
ES (1) ES2214757T3 (zh)
HK (1) HK1027040A1 (zh)
HU (1) HU229052B1 (zh)
ID (1) ID28304A (zh)
IL (1) IL136460A0 (zh)
MY (1) MY126580A (zh)
NO (1) NO327383B1 (zh)
NZ (1) NZ504834A (zh)
PE (1) PE20000012A1 (zh)
PL (1) PL192423B1 (zh)
PT (1) PT1039908E (zh)
SK (1) SK285662B6 (zh)
TW (1) TW527196B (zh)
WO (1) WO1999032118A1 (zh)
ZA (1) ZA9811592B (zh)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6524832B1 (en) 1994-02-04 2003-02-25 Arch Development Corporation DNA damaging agents in combination with tyrosine kinase inhibitors
US6632455B2 (en) 1997-12-22 2003-10-14 Schering Corporation Molecular dispersion composition with enhanced bioavailability
US6316462B1 (en) 1999-04-09 2001-11-13 Schering Corporation Methods of inducing cancer cell death and tumor regression
EP1404300B1 (en) 2001-06-22 2009-09-30 Pfizer Products Inc. Pharmaceutical compositions of dispersions of drugs and neutral polymers
EP1492508A4 (en) * 2002-03-04 2009-05-06 Teva Pharma DOSAGE FORMS WITH CONTROLLED RELEASE
SA07280459B1 (ar) 2006-08-25 2011-07-20 بيورديو فارما إل. بي. أشكال جرعة صيدلانية للتناول عن طريق الفم مقاومة للعبث تشتمل على مسكن شبه أفيوني
PT103661B (pt) 2007-02-23 2010-09-07 Hovione Farmaciencia S A Processo de preparação de minociclina base cristalina
WO2008136392A1 (ja) * 2007-04-27 2008-11-13 Ajinomoto Co., Inc. 経口投与用製剤
US8835635B2 (en) * 2012-06-05 2014-09-16 Symed Labs Limited Amorphous form of vilazodone hydrochloride substantially free of crystalline forms

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2546577B2 (de) * 1975-10-17 1981-04-02 Sandoz-Patent-GmbH, 7850 Lörrach Feste Stoffe aus Polyvinylpyrrolidon und Ergotalkaloiden
EP0214092A1 (en) * 1985-08-08 1987-03-11 Ciba-Geigy Ag Enhanced absorption of psychoactive 2-aryl-pyrazolo quinolines as a solid molecular dispersion in polyvinylpyrrolidone
DE69222182T2 (de) * 1991-12-18 1998-02-26 Warner Lambert Co Verfahren für die herstellung einer festen dispersion
JPH0848632A (ja) * 1994-08-08 1996-02-20 Kanebo Ltd エトポシドを含有する固形組成物および固形製剤
TW350844B (en) * 1995-12-22 1999-01-21 Schering Corp Tricyclic amides useful to inhibition of G-protein function and for treatment of proliferative diseases
ES2224256T3 (es) * 1996-06-28 2005-03-01 Schering Corporation Disolucion solida de un agente antifungico con biodisponibilidad mejorada.

Also Published As

Publication number Publication date
EP1039908B1 (en) 2004-02-25
CO4970793A1 (es) 2000-11-07
NO20003235D0 (no) 2000-06-21
EP1039908A1 (en) 2000-10-04
CZ20002304A3 (cs) 2001-04-11
SK8962000A3 (en) 2001-07-10
CZ295956B6 (cs) 2005-12-14
KR20010033397A (ko) 2001-04-25
DK1039908T3 (da) 2004-05-03
KR100597331B1 (ko) 2006-07-10
AU761994C (en) 2004-01-08
ZA9811592B (en) 1999-06-17
WO1999032118A1 (en) 1999-07-01
AU761994B2 (en) 2003-06-12
ID28304A (id) 2001-05-10
NO20003235L (no) 2000-07-27
CA2315685A1 (en) 1999-07-01
JP2010059212A (ja) 2010-03-18
DE69821984T2 (de) 2004-12-30
CA2315685C (en) 2008-02-05
PE20000012A1 (es) 2000-01-18
PL341344A1 (en) 2001-04-09
ES2214757T3 (es) 2004-09-16
HU229052B1 (en) 2013-07-29
ATE260105T1 (de) 2004-03-15
CN1116039C (zh) 2003-07-30
PT1039908E (pt) 2004-06-30
BR9813728A (pt) 2000-10-10
MY126580A (en) 2006-10-31
CN1282245A (zh) 2001-01-31
NZ504834A (en) 2001-12-21
DE69821984D1 (de) 2004-04-01
IL136460A0 (en) 2001-06-14
NO327383B1 (no) 2009-06-22
AU1814399A (en) 1999-07-12
HK1027040A1 (en) 2001-01-05
AR017436A1 (es) 2001-09-05
HUP0100850A2 (hu) 2001-10-28
PL192423B1 (pl) 2006-10-31
TW527196B (en) 2003-04-11
JP2001526227A (ja) 2001-12-18
HUP0100850A3 (en) 2002-12-28

Similar Documents

Publication Publication Date Title
US5972381A (en) Solid solution of an antifungal agent with enhanced bioavailability
US4673564A (en) Sustained release pharmaceutical composition of solid medical material
US6632455B2 (en) Molecular dispersion composition with enhanced bioavailability
US6936274B2 (en) Storage stable thyroxine active drug formulations and methods for their production
EP0954288B1 (en) Solid solution of an antifungal agent with enhanced bioavailability
US20050027011A1 (en) Serotonin reuptake inhibitor formulations
JP2010059212A (ja) バイオアベイラビリティーを高めた分子分散組成物
KR20090016611A (ko) 메만틴의 약학 조성물
NZ502062A (en) Process for manufacturing paroxetine solid dispersions
EP1938804A1 (en) Pharmaceutical formulation comprising neurokinin antagonist
US7052717B2 (en) Storage stable thyroxine active drug formulations and methods for their production
KR100525275B1 (ko) 시알산 유도체를 함유하는 고체분산체
KR100209201B1 (ko) 1,4-디히드로피리딘 유도체를 함유하는 고체 분산 정제 및 그의 제조방법
US20080125453A1 (en) Phenylephrine tannate, pyrilamine tannate and dextromethorphan tannate salts in pharmaceutical compositions
EP0487335A1 (en) Pharmaceutical dosage forms of dihydropyridines
EP3520792A1 (en) Pharmaceutical composition for preventing or treating dementia and cognitive dysfunction, containing donepezil or pharmaceutically acceptable salt thereof and memantine or pharmaceutically acceptable salt thereof, and preparation method therefor
MXPA00006185A (en) Molecular dispersion composition with enhanced bioavailability
CA2258679C (en) Solid solution of an antifungal agent with enhanced bioavailability
KR20050039126A (ko) 디히드로피리딘계 화합물의 서방출성 제제 및 그 제조방법

Legal Events

Date Code Title Description
TC4A Change of owner's name

Owner name: MERCK SHARP & DOHME CORP., RAHWAY, NJ, US

Effective date: 20121108

MM4A Patent lapsed due to non-payment of maintenance fees

Effective date: 20141217